CareDx, IDbyDNA Partner to Develop Infectious Disease Dx for Transplant Patients

Jan 07, 2021

|

NEW YORK – Transplant diagnostics firm CareDx and precision metagenomics company IDbyDNA said on Thursday that they've formed an exclusive partnership to develop metagenomic infectious disease testing specific to transplant patients.

Financial terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

CareDx, IDbyDNA Partner to Develop Infectious Disease Dx for Transplant Patients

To read the full story....

Breaking News

Danaher Q4 Revenues Up 39 Percent

Ortho Clinical Diagnostics Prices $1.29B IPO

Hologic Fiscal Q1 Revenues Rise 89 Percent as Dx Testing Demand Surges

Spectrum Solutions, UCLA Partner to Study Saliva-Based Early-Stage Lung Cancer Detection

T2 Biosystems Preliminary Q4 Revenues Grow 155 Percent, Miss Estimates

Abbott Q4 Diagnostics Revenues Up 111 Percent, FY20 Revenues Up 9 Percent

What's Popular?

Abbott Q4 Diagnostics Revenues Up 111 Percent, FY20 Revenues Up 9 Percent

T2 Biosystems Preliminary Q4 Revenues Grow 155 Percent, Miss Estimates

Ambry Genetics Gets FDA Emergency Use Authorization for Coronavirus Test

Roche Renews Agreement to Distribute Sysmex Hematology Products

Abbott Continuing Focus on Rapid Testing in Light of COVID-19 Pandemic

Sponsorships